Clinical Trial: Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214857) titled 'Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States' on Oct. 06.

Brief Summary: The aim of this study was to estimate the number of United States (US) adults with and without prior atherosclerotic cardiovascular disease (ASCVD) and diabetes who may be eligible for inclisiran based on US National Health and Nutrition Examination Survey (NHANES) data and inclisiran eligibility criteria from ongoing clinical trials as well as to estimate the number of preventable ASCVD events based on expected risk reductions from the degree of low-density lipoprotein cholesterol ...